Carl Basamania, MD
Orthopaedic Surgery · Seattle, WANPI 1295822930
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.3%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 39.8% of the total. Reporting peaked in 2020 at $86,450 and has fallen 53.5% since, to $40,178 in 2025. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $1843.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$142K
- Zimmer Biomet$141K
- Depuy Synthes Products, Inc.$70K
- Arthrex$1K
- Summit Surgical Corp.$1K
- Johnson & Johnson$458
- plus $139 from 2 others
What the payments were for
- Royalty or licence$153,67443%
- Consulting fees$179,04550%
- Travel & lodging$17,8775%
- Food & beverage$2,7241%
- Education$2,4991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 71 | $141,590 |
| Zimmer Biomet | 47 | $141,339 |
| Depuy Synthes Products, Inc. | 60 | $69,767 |
| Arthrex | 3 | $1,327 |
| Summit Surgical Corp. | 1 | $1,200 |
| Johnson & Johnson | 9 | $458 |
| Pacira Pharmaceuticals Incorporated | 1 | $87 |
| Stryker | 1 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- A.L.P.S.$124,083
- GLOBAL$68,020
- DELTA$63,118
- GRYPHON$47,133
- HEALIX$45,727
- Gryphon Orthocord$40,030
- HEALIX KNOTLESS PEEK$40,030
- BIOLOX DELTA$37,142
- Alps Plates and Instruments$11,873
- Alps Clavicle$2,306
- Periarticular Locking Plates$2,250
- NCB Instruments/Plates/Screws$2,250
- TRUMATCH$2,055
- ENDURANCE$1,846
- EXPAREL$1,485
- Trauma Product Portfolio$144
How this compares
$355,819 in reported general payments places this provider in the 95th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 229 | $6,016 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $93 |
| Amoxicillin | 19 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Seattle
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Burt YaszaySeattle$1.3M
- Sean ToomeySeattle$1.2M
- Robert HartSeattle$942K
- Jeffrey RohSeattle$604K
- Michael BrageSeattle$496K
- Daniel SchwartzSeattle$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.